8QE-33840-11563
1 vaccination
1 coded response
5 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 852 / AZ
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-01
Registered in v-safe
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-04-03
- 2021-07-02
- 2021-09-29
-
2022-04-02
Survey response — 12 months, dose 1MedDRA: Vitamin D deficiency — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Vitamin d deficiencyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Report sent to call center — 12 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Janssen/Johnson & Johnson |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 1
Symptoms: Vitamin d deficiency
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Vitamin D deficiency | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release